Elanco Animal Health Quarterly Balance Sheets Chart
Quarterly
|
Annual
Elanco Animal Health Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | ||||||||||||||||||||||||||
| current assets | ||||||||||||||||||||||||||
| cash and cash equivalents | 539,000,000 | 487,000,000 | 468,000,000 | 490,000,000 | 416,000,000 | 345,000,000 | 352,000,000 | 369,000,000 | 367,000,000 | 318,000,000 | 345,000,000 | 460,000,000 | 507,000,000 | 342,000,000 | 638,000,000 | 453,000,000 | 580,000,000 | 515,000,000 | 494,700,000 | 659,900,000 | 1,391,100,000 | 1,206,400,000 | 334,000,000 | 309,200,000 | 385,100,000 | 272,100,000 |
| accounts receivable | 989,000,000 | 970,000,000 | 805,000,000 | 840,000,000 | 999,000,000 | 988,000,000 | 842,000,000 | 911,000,000 | 1,000,000,000 | 1,051,000,000 | 797,000,000 | 804,000,000 | 916,000,000 | 973,000,000 | 833,000,000 | 924,000,000 | 1,067,000,000 | 1,028,000,000 | 871,600,000 | 762,300,000 | 543,900,000 | 676,800,000 | 816,900,000 | 758,300,000 | 757,200,000 | 684,100,000 |
| other receivables | 114,000,000 | 90,000,000 | 81,000,000 | 64,000,000 | 81,000,000 | 90,000,000 | 168,000,000 | 224,000,000 | 225,000,000 | 213,000,000 | 205,000,000 | 224,000,000 | 212,000,000 | 219,000,000 | 195,000,000 | 158,000,000 | 107,000,000 | 104,000,000 | 205,100,000 | 70,800,000 | 72,900,000 | 66,900,000 | 73,000,000 | 65,100,000 | 74,300,000 | 107,800,000 |
| inventories | 1,670,000,000 | 1,592,000,000 | 1,574,000,000 | 1,632,000,000 | 1,611,000,000 | 1,638,000,000 | 1,735,000,000 | 1,690,000,000 | 1,690,000,000 | 1,596,000,000 | 1,538,000,000 | 1,340,000,000 | 1,334,000,000 | 1,345,000,000 | 1,373,000,000 | 1,383,000,000 | 1,450,000,000 | 1,424,000,000 | 1,578,100,000 | 1,597,100,000 | 1,065,300,000 | 1,019,000,000 | 1,050,700,000 | 1,068,700,000 | 1,053,100,000 | 1,035,500,000 |
| prepaid expenses and other | 302,000,000 | 301,000,000 | 287,000,000 | 340,000,000 | 277,000,000 | 338,000,000 | 310,000,000 | 371,000,000 | 370,000,000 | 370,000,000 | 394,000,000 | 326,000,000 | 338,000,000 | 315,000,000 | 237,000,000 | 242,000,000 | 227,000,000 | 273,000,000 | 256,300,000 | 180,600,000 | 107,400,000 | 132,100,000 | 87,400,000 | 98,000,000 | 102,300,000 | 114,800,000 |
| total current assets | 3,614,000,000 | 3,440,000,000 | 3,215,000,000 | 3,366,000,000 | 4,011,000,000 | 4,050,000,000 | 3,407,000,000 | 3,565,000,000 | 3,652,000,000 | 3,548,000,000 | 3,279,000,000 | 3,154,000,000 | 3,307,000,000 | 3,194,000,000 | 3,276,000,000 | 3,160,000,000 | 3,431,000,000 | 3,344,000,000 | 3,416,500,000 | 3,281,400,000 | 3,191,300,000 | 3,120,600,000 | 2,373,100,000 | 2,310,400,000 | 2,383,500,000 | 2,278,300,000 |
| noncurrent assets | ||||||||||||||||||||||||||
| property and equipment | 1,357,000,000 | 1,047,000,000 | 993,000,000 | 979,000,000 | 949,000,000 | 949,000,000 | 1,026,000,000 | 992,000,000 | 1,007,000,000 | 999,000,000 | 1,061,000,000 | 1,316,300,000 | 955,300,000 | |||||||||||||
| goodwill | 4,758,000,000 | 4,508,000,000 | 4,414,000,000 | 4,625,000,000 | 4,480,000,000 | 4,478,000,000 | 5,094,000,000 | 4,902,000,000 | 6,040,000,000 | 6,061,000,000 | 5,993,000,000 | 5,716,000,000 | 5,898,000,000 | 6,116,000,000 | 6,172,000,000 | 6,191,000,000 | 6,239,000,000 | 6,016,000,000 | 6,224,800,000 | 6,434,700,000 | 3,044,000,000 | 3,004,000,000 | 2,989,600,000 | 2,946,400,000 | 2,959,600,000 | 2,933,100,000 |
| other intangibles | 3,705,000,000 | 3,634,000,000 | 3,681,000,000 | 4,011,000,000 | 4,000,000,000 | 4,196,000,000 | 4,494,000,000 | 4,475,000,000 | 4,678,000,000 | 4,791,000,000 | 4,842,000,000 | 4,766,000,000 | 5,059,000,000 | 5,395,000,000 | 5,587,000,000 | 5,816,000,000 | 5,755,000,000 | 6,032,000,000 | 6,387,300,000 | 5,785,600,000 | 2,432,700,000 | 2,455,500,000 | 2,482,800,000 | 2,435,000,000 | 2,352,800,000 | 2,386,500,000 |
| other noncurrent assets | 308,000,000 | 312,000,000 | 311,000,000 | 302,000,000 | 324,000,000 | 346,000,000 | 341,000,000 | 410,000,000 | 419,000,000 | 369,000,000 | 378,000,000 | 376,000,000 | 376,000,000 | 559,000,000 | 387,000,000 | 357,000,000 | 375,000,000 | 325,000,000 | 347,800,000 | 492,800,000 | 283,900,000 | 217,000,000 | 185,000,000 | 220,200,000 | 229,900,000 | 219,300,000 |
| total assets | 13,742,000,000 | 12,941,000,000 | 12,614,000,000 | 13,283,000,000 | 13,764,000,000 | 14,019,000,000 | 14,362,000,000 | 14,344,000,000 | 15,796,000,000 | 15,769,000,000 | 15,491,000,000 | 14,948,000,000 | 15,601,000,000 | 16,251,000,000 | 16,483,000,000 | 16,565,000,000 | 16,833,000,000 | 16,988,000,000 | 17,692,700,000 | 17,237,000,000 | 9,876,000,000 | 9,727,200,000 | 8,985,800,000 | 8,823,700,000 | 8,856,900,000 | 8,747,400,000 |
| liabilities and equity | ||||||||||||||||||||||||||
| current liabilities | ||||||||||||||||||||||||||
| accounts payable | 368,000,000 | 330,000,000 | 296,000,000 | 259,000,000 | 291,000,000 | 302,000,000 | 270,000,000 | 296,000,000 | 354,000,000 | 381,000,000 | 390,000,000 | 350,000,000 | 386,000,000 | 402,000,000 | 418,000,000 | 436,000,000 | 506,000,000 | 411,000,000 | 501,000,000 | 355,900,000 | 242,500,000 | 215,000,000 | 222,600,000 | 206,100,000 | 242,900,000 | 252,100,000 |
| sales rebates and discounts | 367,000,000 | 319,000,000 | 332,000,000 | 333,000,000 | 356,000,000 | 318,000,000 | 367,000,000 | 356,000,000 | 332,000,000 | 329,000,000 | 324,000,000 | 298,000,000 | 284,000,000 | 295,000,000 | 316,000,000 | 316,000,000 | 303,000,000 | 331,000,000 | 295,300,000 | 278,600,000 | 164,000,000 | 192,700,000 | 211,000,000 | 182,200,000 | 176,000,000 | 171,700,000 |
| current portion of long-term debt and finance lease liability | 61,000,000 | |||||||||||||||||||||||||
| other current liabilities | 596,000,000 | 576,000,000 | 466,000,000 | 685,000,000 | 510,000,000 | 574,000,000 | 409,000,000 | 574,000,000 | 559,000,000 | 377,000,000 | 454,000,000 | 435,000,000 | 499,000,000 | 438,000,000 | 430,000,000 | 390,000,000 | 502,000,000 | 573,000,000 | 576,900,000 | 531,900,000 | 321,700,000 | 217,600,000 | 244,400,000 | 181,500,000 | 205,400,000 | 191,200,000 |
| total current liabilities | 1,392,000,000 | 1,269,000,000 | 1,315,000,000 | 1,321,000,000 | 1,370,000,000 | 1,232,000,000 | 1,241,000,000 | 1,265,000,000 | 1,284,000,000 | 1,578,000,000 | 1,702,000,000 | 1,613,000,000 | 1,338,000,000 | 1,307,000,000 | 1,643,000,000 | 1,362,000,000 | 1,990,000,000 | 2,034,000,000 | 2,076,300,000 | 1,871,200,000 | 835,400,000 | 707,500,000 | 818,500,000 | 741,500,000 | 777,500,000 | 708,200,000 |
| noncurrent liabilities | ||||||||||||||||||||||||||
| long-term debt and finance lease liability | 4,148,000,000 | |||||||||||||||||||||||||
| liability for sale of future revenue | 293,000,000 | |||||||||||||||||||||||||
| deferred taxes | 496,000,000 | 481,000,000 | 449,000,000 | 539,000,000 | 524,000,000 | 530,000,000 | 567,000,000 | 643,000,000 | 658,000,000 | 663,000,000 | 662,000,000 | 618,000,000 | 620,000,000 | 747,000,000 | 745,000,000 | 726,000,000 | 767,000,000 | 828,000,000 | 900,300,000 | 823,100,000 | 65,500,000 | 90,200,000 | 100,800,000 | 81,100,000 | 147,800,000 | 131,800,000 |
| other noncurrent liabilities | 638,000,000 | 487,000,000 | 302,000,000 | 587,000,000 | 465,000,000 | 474,000,000 | 411,000,000 | 432,000,000 | 411,000,000 | 245,000,000 | 229,000,000 | 225,000,000 | 242,000,000 | 242,000,000 | 261,000,000 | 220,000,000 | 237,000,000 | 247,000,000 | 322,100,000 | 312,900,000 | 208,900,000 | 150,300,000 | 106,600,000 | 96,400,000 | 175,700,000 | 168,400,000 |
| total liabilities | 6,967,000,000 | 6,588,000,000 | 6,518,000,000 | 6,760,000,000 | 7,822,000,000 | 7,963,000,000 | 8,139,000,000 | 8,210,000,000 | 8,376,000,000 | 8,289,000,000 | 8,202,000,000 | 8,203,000,000 | 8,461,000,000 | 8,639,000,000 | 8,945,000,000 | 8,883,000,000 | 8,853,000,000 | 8,981,000,000 | 9,216,800,000 | 8,892,800,000 | 3,224,100,000 | 3,065,700,000 | 3,438,900,000 | 3,336,000,000 | 3,591,400,000 | 3,551,200,000 |
| commitments and contingencies | ||||||||||||||||||||||||||
| equity | ||||||||||||||||||||||||||
| common stock | ||||||||||||||||||||||||||
| additional paid-in capital | 8,839,000,000 | 8,819,000,000 | 8,817,000,000 | 8,804,000,000 | 8,790,000,000 | 8,777,000,000 | 8,777,000,000 | 8,763,000,000 | 8,752,000,000 | 8,744,000,000 | 8,738,000,000 | 8,724,000,000 | 8,712,000,000 | 8,699,000,000 | 8,696,000,000 | 8,680,000,000 | 8,663,000,000 | 8,647,000,000 | 8,650,100,000 | 8,620,400,000 | 6,886,100,000 | 6,870,300,000 | 5,636,300,000 | 5,646,400,000 | 5,396,500,000 | 5,398,700,000 |
| accumulated deficit | -1,872,000,000 | -1,883,000,000 | -1,950,000,000 | -1,942,000,000 | -2,306,000,000 | -2,256,000,000 | -2,288,000,000 | -2,147,000,000 | -1,051,000,000 | -954,000,000 | -1,057,000,000 | -972,000,000 | -923,000,000 | -901,000,000 | -949,000,000 | -852,000,000 | -748,000,000 | -538,000,000 | ||||||||
| accumulated other comprehensive loss | -192,000,000 | -583,000,000 | -771,000,000 | -339,000,000 | -542,000,000 | -465,000,000 | -266,000,000 | -482,000,000 | -281,000,000 | -310,000,000 | -392,000,000 | -1,007,000,000 | -649,000,000 | -186,000,000 | -121,800,000 | -214,800,000 | -242,600,000 | -173,700,000 | -252,500,000 | -214,800,000 | -250,400,000 | |||||
| total equity | 6,775,000,000 | 6,353,000,000 | 6,096,000,000 | 6,523,000,000 | 5,942,000,000 | 6,056,000,000 | 6,223,000,000 | 6,134,000,000 | 7,420,000,000 | 7,480,000,000 | 7,289,000,000 | 6,745,000,000 | 7,140,000,000 | 7,612,000,000 | 7,538,000,000 | 7,682,000,000 | 7,980,000,000 | 8,007,000,000 | 8,475,900,000 | 8,344,200,000 | 6,651,900,000 | 6,661,500,000 | 5,546,900,000 | 5,487,700,000 | 5,265,500,000 | 5,196,200,000 |
| total liabilities and equity | 13,742,000,000 | 12,941,000,000 | 12,614,000,000 | 13,283,000,000 | 13,764,000,000 | 14,019,000,000 | 14,362,000,000 | 14,344,000,000 | 15,796,000,000 | 15,769,000,000 | 15,491,000,000 | 14,948,000,000 | 15,601,000,000 | 16,251,000,000 | 16,483,000,000 | 16,565,000,000 | 16,833,000,000 | 16,988,000,000 | 17,692,700,000 | 17,237,000,000 | 9,876,000,000 | 9,727,200,000 | 8,985,800,000 | 8,823,700,000 | 8,856,900,000 | 8,747,400,000 |
| current portion of long-term debt | 44,000,000 | 44,000,000 | 44,000,000 | 213,000,000 | 38,000,000 | 38,000,000 | 39,000,000 | 39,000,000 | 381,000,000 | 388,000,000 | 394,000,000 | 56,000,000 | 61,000,000 | 294,000,000 | 61,000,000 | 555,000,000 | 605,000,000 | 554,500,000 | 553,600,000 | 25,900,000 | 26,000,000 | 24,500,000 | 27,100,000 | 29,000,000 | ||
| long-term debt | 4,351,000,000 | 4,277,000,000 | 4,313,000,000 | 5,463,000,000 | 5,727,000,000 | 5,736,000,000 | 5,870,000,000 | 6,023,000,000 | 5,639,000,000 | 5,448,000,000 | 5,507,000,000 | 6,007,000,000 | 6,073,000,000 | 6,025,000,000 | 6,273,000,000 | 5,542,000,000 | 5,556,000,000 | 5,572,400,000 | 5,586,500,000 | 2,030,400,000 | 2,035,600,000 | 2,330,500,000 | 2,335,600,000 | 2,382,000,000 | 2,436,600,000 | |
| employee compensation | 177,000,000 | 157,000,000 | 110,000,000 | 146,000,000 | 136,000,000 | 113,000,000 | 111,000,000 | 185,000,000 | 159,000,000 | 124,000,000 | 114,000,000 | 143,600,000 | 139,900,000 | 57,200,000 | 56,200,000 | 99,600,000 | 88,800,000 | 67,300,000 | 64,200,000 | |||||||
| accrued retirement benefits | 175,000,000 | 184,000,000 | 164,000,000 | 161,000,000 | 240,000,000 | 254,000,000 | 270,000,000 | 271,000,000 | 302,000,000 | 317,000,000 | 316,000,000 | 345,700,000 | 299,100,000 | 83,900,000 | 82,100,000 | 82,500,000 | 81,400,000 | 108,400,000 | 106,200,000 | |||||||
| assets held for sale | 627,000,000 | 651,000,000 | ||||||||||||||||||||||||
| property and equipment, net of accumulated depreciation of 744 | 1,000,000,000 | |||||||||||||||||||||||||
| preferred stock, no par value, 1,000,000,000 shares authorized; none issued | ||||||||||||||||||||||||||
| preferred stock, 1,000,000,000 shares authorized, no par value; none issued | ||||||||||||||||||||||||||
| property and equipment, net of accumulated depreciation of 696 | 936,000,000 | |||||||||||||||||||||||||
| property and equipment, net of accumulated depreciation of 688 | 961,000,000 | |||||||||||||||||||||||||
| property and equipment, net of accumulated depreciation of 670 | 987,000,000 | |||||||||||||||||||||||||
| restricted cash | 10,700,000 | 10,700,000 | 10,700,000 | 10,700,000 | 11,100,000 | 11,100,000 | 11,500,000 | 28,500,000 | ||||||||||||||||||
| accumulated other comprehensive income | -209,000,000 | -146,000,000 | 65,000,000 | -102,000,000 | 303,000,000 | |||||||||||||||||||||
| property and equipment, net of accumulated depreciation of 1,050 | 1,041,000,000 | |||||||||||||||||||||||||
| property and equipment, net of accumulated depreciation of 1,054 | 1,033,000,000 | |||||||||||||||||||||||||
| property and equipment, net of accumulated depreciation of 1,060 | 1,271,000,000 | |||||||||||||||||||||||||
| payable to lilly | 5,000,000 | 11,300,000 | 24,100,000 | 16,400,000 | 58,400,000 | 58,800,000 | ||||||||||||||||||||
| retained earnings | -477,200,000 | -154,400,000 | -19,400,000 | 33,800,000 | 84,300,000 | 93,800,000 | 83,800,000 | 47,900,000 | ||||||||||||||||||
| property and equipment, net of accumulated depreciation of 982.7 | 1,242,500,000 | |||||||||||||||||||||||||
| property and equipment, net of accumulated depreciation of 942.1 | 924,100,000 | |||||||||||||||||||||||||
| receivable from lilly | 8,700,000 | 35,500,000 | ||||||||||||||||||||||||
| property and equipment, net of accumulated depreciation of 919.7 | 930,100,000 | |||||||||||||||||||||||||
| current portion of long term debt | 24,500,000 | |||||||||||||||||||||||||
| property and equipment, net of accumulated depreciation of 909.3 | 911,700,000 | |||||||||||||||||||||||||
| property and equipment, net of accumulated depreciation of 921.2 | 931,100,000 | |||||||||||||||||||||||||
| december 31, 2017 | 293,300,000 | 293,300,000 | ||||||||||||||||||||||||
| adoption of accounting standards update 2016-16 | ||||||||||||||||||||||||||
| net income | ||||||||||||||||||||||||||
| other comprehensive income, net of tax | ||||||||||||||||||||||||||
| transfers (to)/from lilly | ||||||||||||||||||||||||||
| march 31, 2018 | 293,300,000 | 293,300,000 | ||||||||||||||||||||||||
| june 30, 2018 | 293,300,000 | |||||||||||||||||||||||||
| december 31, 2018 | 365,600,000 | 365,600,000 | ||||||||||||||||||||||||
| separation activities | ||||||||||||||||||||||||||
| stock compensation | ||||||||||||||||||||||||||
| issuance of stock under employee stock plans | 100,000 | 100,000 | ||||||||||||||||||||||||
| march 31, 2019 | 365,700,000 | 365,700,000 | ||||||||||||||||||||||||
| other | ||||||||||||||||||||||||||
| june 30, 2019 | 365,700,000 | |||||||||||||||||||||||||
| property and equipment, net of accumulated depreciation 909.3 | 930,200,000 | |||||||||||||||||||||||||
| net capital contributions from/(distributions to) lilly |
We provide you with 20 years of balance sheets for Elanco Animal Health stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Elanco Animal Health. Explore the full financial landscape of Elanco Animal Health stock with our expertly curated balance sheets.
The information provided in this report about Elanco Animal Health stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.